ERYTECH successfully raises €30 million for expanding its therapeutic indications in oncology and accelerating its clinical developments Post author:admERY Post published:October 23, 2014 Post category:Newsroom ERYTECH announces today the successful completion of a capital increase for a total amount of €30 million. You Might Also Like ERYTECH to Present at Jefferies 2019 HealthCare Conference in London November 14, 2019 ERYTECH Appoints Stewart Craig as Chief Technical Officer October 26, 2020 ERYTECH to Host Fourth Quarter and Full Year 2018 Conference Call and Business Update March 6, 2019
